Stopping short the spread of methicillin-resistant Staphylococcus aureus

CMAJ. Canadian Medical Association Journal

Volumn 165, Issue 1, 2001, Pages 31-32

  Verhoef, J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; TEICOPLANIN; VANCOMYCIN;

BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CANADA; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DNA FINGERPRINTING; ENDOCARDITIS; EPIDEMIC; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOTE; PATIENT CARE; PENICILLIN RESISTANCE; SCREENING; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

EID: 0034927263     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (8)

1. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 Years of national surveillance
2. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the sentry antimicrobial surveillance program, 1997-1999
3. A Dutch approach to methicillin-resistant Staphylococcus aureus
4. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia. At what costs?
5. Methicillin-resistant Staphylococcus aureus in Europe
6. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
7. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals